J. Timothy Greenamyre
Affiliations: | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
Parkinson's Disease, Huntington's DiseaseGoogle:
"J. Timothy Greenamyre"Mean distance: 15.16 (cluster 32) | S | N | B | C | P |
Parents
Sign in to add mentorAnne B. Young | grad student | University of Michigan | |
Jack Penney | grad student | 1980-1986 | University of Michigan Medical School |
Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Keeney MT, Rocha EM, Hoffman EK, et al. (2024) LRRK2 regulates production of reactive oxygen species in cell and animal models of Parkinson's disease. Science Translational Medicine. 16: eadl3438 |
Pullara F, Forsmann MC, General IJ, et al. (2024) NADPH oxidase 2 activity disrupts Calmodulin/CaMKIIα complex via redox modifications of CaMKIIα-contained Cys30 and Cys289: Implications in Parkinson's disease. Redox Biology. 75: 103254 |
Keeney MT, Hoffman EK, Weir J, et al. (2024) 15-Lipoxygenase-Mediated Lipid Peroxidation Regulates LRRK2 Kinase Activity. Biorxiv : the Preprint Server For Biology |
Ilieva NM, Hoffman EK, Ghalib MA, et al. (2024) LRRK2 kinase inhibition protects against Parkinson's disease-associated environmental toxicants. Neurobiology of Disease. 106522 |
Van Laar AD, Webb KR, Keeney MT, et al. (2023) Transient exposure to rotenone causes degeneration and progressive parkinsonian motor deficits, neuroinflammation, and synucleinopathy. Npj Parkinson's Disease. 9: 121 |
Di Maio R, Keeney MT, Cechova V, et al. (2023) Neuroprotective actions of a fatty acid nitroalkene in Parkinson's disease. Npj Parkinson's Disease. 9: 55 |
Hallacli E, Kayatekin C, Nazeen S, et al. (2022) The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability. Cell. 185: 2035-2056.e33 |
Keeney MT, Hoffman EK, Farmer K, et al. (2022) NADPH oxidase 2 activity in Parkinson's disease. Neurobiology of Disease. 105754 |
Rocha EM, Keeney MT, Di Maio R, et al. (2022) LRRK2 and idiopathic Parkinson's disease. Trends in Neurosciences |
De Miranda BR, Goldman SM, Miller GW, et al. (2021) Preventing Parkinson's Disease: An Environmental Agenda. Journal of Parkinson's Disease |